The CTX-M β-lactamase pandemic

被引:892
作者
Canton, Rafael [1 ]
Coque, Teresa M. [1 ]
机构
[1] Hosp Ramon & Cajal, Microbiol Serv, E-28034 Madrid, Spain
关键词
D O I
10.1016/j.mib.2006.08.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the past decade CTX-M enzymes have become the most prevalent extended-spectrum beta-lactamases, both in nosocomial and in community settings. The insertion sequences (ISs) ISEcp1 and ISCR1 (formerly common region 1 [CR1] or orf513) appear to enable the mobilization of chromosomal beta-lactamase Kluyvera species genes, which display high homology with bla(CTX-Ms). These ISs are preferentially linked to specific genes: ISEcp1 to most bla(CTX-Ms), and ISCR1 to bla(CTX-M-2) or bla(CTX-M-9). The bla(CTX-M) genes embedded in class 1 integrons bearing ISCR1 are associated with different Tn402-derivatives, and often with mercury Tn21-like transposons. The bla(CTX-M) genes linked to ISEcp1 are often located in multidrug resistance regions containing different transposons and ISs. These structures have been located in narrow and broad host-range plasmids belonging to the same incompatibility groups as those of early antibiotic resistance plasmids. These plasmids frequently carry aminoglycoside, tetracycline, sulfonamide or fluoroquinolone resistance genes [qnr and/or aac(6')-lb-cr], which would have facilitated the dissemination of bla(CTX-M) genes because of co-selection processes. In Escherichia coli, they are frequently carried in well-adapted phylogenetic groups with particular virulence-factor genotypes. Also, dissemination has been associated with different clones (CTX-M-9 or CTX-M-14 producers) or epidemic clones associated with specific enzymes such as CTX-M-15. All these events might have contributed to the current pandemic CTX-M beta-lactamase scenario.
引用
收藏
页码:466 / 475
页数:10
相关论文
共 58 条
[1]  
[Anonymous], ANTIMICROB AGENTS CH
[2]   Influx of extended-spectrum β-lactamase producing enterobacteriaceae into the hospital [J].
Ben-Ami, R ;
Schwaber, MJ ;
Navon-Venezia, S ;
Schwartz, D ;
Giladi, M ;
Chmelnitsky, I ;
Leavitt, A ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) :925-934
[3]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[4]   Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada [J].
Boyd, DA ;
Tyler, S ;
Christianson, S ;
McGeer, A ;
Muller, MP ;
Willey, BM ;
Bryce, E ;
Gardam, M ;
Nordmann, P ;
Mulvey, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3758-3764
[5]   Genetic background of Escherichia coli and extended-spectrum β-lactamase type [J].
Branger, C ;
Zamfir, O ;
Geoffroy, S ;
Laurans, G ;
Arlet, G ;
Thien, HV ;
Gouriou, S ;
Picard, B ;
Denamur, E .
EMERGING INFECTIOUS DISEASES, 2005, 11 (01) :54-61
[6]   Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients [J].
Brigante, G ;
Luzzaro, F ;
Perilli, M ;
Lombardi, G ;
Colì, A ;
Rossolini, GM ;
Amicosante, G ;
Toniolo, A .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (02) :157-162
[7]   Multi-resistant Gram-negative bacilli:: from epidemics to endemics [J].
Cantón, R ;
Coque, TM ;
Baquero, F .
CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (04) :315-325
[8]   Identification of plasmids by PCR-based replicon typing [J].
Carattoli, A ;
Bertini, A ;
Villa, L ;
Falbo, V ;
Hopkins, KL ;
Threlfall, EJ .
JOURNAL OF MICROBIOLOGICAL METHODS, 2005, 63 (03) :219-228
[9]   Extended-spectrum β-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003 [J].
Carattoli, A ;
Lovari, S ;
Franco, A ;
Cordaro, G ;
Di Matteo, P ;
Battisti, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :833-835
[10]   Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals [J].
Celenza, G ;
Pellegrini, C ;
Caccamo, M ;
Segatore, B ;
Amicosante, G ;
Perilli, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (05) :975-978